Canada Markets open in 2 hrs 53 mins

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5985-0.0015 (-0.25%)
At close: 10:31AM EST
Full screen
Loading interactive chart...
  • GlobeNewswire

    Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

    The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the futureLevitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs informing patients about the Canntab portfolio of therapeuticsLevitee Labs will offer the entire Canntab product lineup throughout all its clinics and pharmacies in Western Canada VANCOUVER, British Columbia, Jan. 10,

  • CNW Group

    CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

    Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.

  • CNW Group

    CANNTAB ENTERS INTO STRATEGIC PARTNERSHIP TO PROVIDE ALTERNATIVES TO OPIATES THROUGH LEVITEE CLINICS

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has entered into a service agreement (the "Agreement") with Levitee Clinics Inc. ("Levitee"). Servicing over 35,000 patient visits in last 12 months, Levitee is establishing itself as a leader in the integrative wellness space. Levitee aims to transform mental h